Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Articles
Filter
Filter
Sort By
Newest First
Sector
Modality / Product
Service / Activity
Reset
Sign in
1 / 9
1 / 9
NIH
The White House’s War on the NIH and the Disasters Ahead
David Alvaro, Ph.D.
Pharma's Almanac
PAO-03-25-NI-05
Mar 24, 2025
Leadership Wisdom
Conversations with Carleone: Leadership Wisdom Worth Sharing
Joseph Carleone; Emilee Kudla
Carleone Partners
PAO-03-25-NI-02
Mar 14, 2025
Federal Job Cuts
Science Under Siege: The Devastating Consequences of Public Health and Research Cuts
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-04
Feb 19, 2025
NIH Funding
NIH Funding Cuts Put Innovation, Health Equity, and Lives at Risk
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-03
Feb 10, 2025
Financing
Why Life Science Companies Surged amid a Global M&A Downturn
Amanda Wang
That's Nice LLC
PAO-10-24-CL-11
Oct 15, 2024
AI
Plan Ahead: Mastering Your AI Budget for 2025 Success
Stephen Tharp
Dotmatics
PAO-10-24-CL-06
Oct 07, 2024
Process Development
Economic Benefits of Digital Process Development
Fabian Feidl, Ph.D.
DataHow
PAO-10-24-CL-02
Sep 24, 2024
Digitalization
Radical Bioprocessing Efficiencies and Cost Reductions — The Next Wave of Biopharmaceutical Innovation
Michael Sokolov, Ph.D.
DataHow
PAO-08-24-CL-02
Aug 26, 2024
Training
Biotech Training is a Challenge
April Stanley, MS MBA; Koey Keylon
Nice Insight
PAO-06-24-NI-01
Jun 11, 2024
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
Esther Yoo, Ph.D.
Samsung Biologics
PAO-11-022-CL-02
Nov 16, 2022
Cosmeceuticals
Cosmeceuticals Are Here. When Will Regulations Catch Up?
Ameena Pathan
That's Nice LLC
PAO-08-022-CL-09
Aug 31, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12
Jun 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
Jun 24, 2022
Column: Investment
2021 Was a Great Year for Biotech IPOs, Depending on When You Got Out
Danielle Alvarez
Pharma's Almanac
PAO-03-022-NI-07
Mar 23, 2022
Investment
Global Investment Trends and Getting Noticed by PE/VC Firms
Iesan Tsai
Kiri Capital
PAO-02-022-CL-15
Mar 15, 2022
COVID-19 Vaccines
The Global Immunization Disparity
Komal Hatti
IPS-Integrated Project Services, LLC
PAO-02-022-CL-04
Mar 12, 2022
Biologics
An Evolving Biologics Landscape and Driving Innovation and Opportunity
Tim Roberts
PCI Pharma Services
PAO-11-21-CL-16
Nov 30, 2021
Investing in mRNA Production
Michael Wourms
Arranta Bio
PA766
Nov 22, 2021
Big Data
Helping Life Science Companies With Big Data Challenges
Steve Yemm; Satnam Surae, PhD,
PTV-07-21-CL-001-835
Jul 28, 2021
Strategic Growth
Unique Commercial Experience Primes Avid Bioservices for Growth
Nicholas Green
Avid Bioservices
PAO-05-21-CL-03
May 12, 2021
